Cefotiam Dihydrochloride is a broad-spectrum, third-generation cephalosporin β-lactam antibiotic that was patented in 1973. It interferes with bacterial peptidoglycan synthesis. It is commonly used in antimicrobial susceptibility testing, and is effective against MRSA.
Cefotiam Dihydrochloride is freely soluble in water.
